GLP Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
23 juil. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, July 23, 2024 (GLOBE NEWSWIRE) -- GLP Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The...